{"id":"https://openalex.org/W2124773873","doi":"https://doi.org/10.1177/1074248407313151","title":"Pharmacoeconomic Concepts in Antiplatelet Therapy: Understanding Cost-Effectiveness Analyses Using Clopidogrel as an Example","display_name":"Pharmacoeconomic Concepts in Antiplatelet Therapy: Understanding Cost-Effectiveness Analyses Using Clopidogrel as an Example","publication_year":2008,"publication_date":"2008-05-21","ids":{"openalex":"https://openalex.org/W2124773873","doi":"https://doi.org/10.1177/1074248407313151","mag":"2124773873","pmid":"https://pubmed.ncbi.nlm.nih.gov/18495905"},"language":"en","primary_location":{"id":"doi:10.1177/1074248407313151","doi":"https://doi.org/10.1177/1074248407313151","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1074248407313151","pdf_url":null,"source":{"id":"https://openalex.org/S130832228","display_name":"Journal of Cardiovascular Pharmacology and Therapeutics","issn_l":"1074-2484","issn":["1074-2484","1940-4034"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052993534","display_name":"William S. Weintraub","orcid":"https://orcid.org/0000-0002-5384-5571","observed_orcids":["https://orcid.org/0000-0002-5384-5571"]},"institutions":[{"id":"https://openalex.org/I1281704429","display_name":"Christiana Care Health System","ror":"https://ror.org/02h905004","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1281704429"]},{"id":"https://openalex.org/I4210105554","display_name":"Christiana Hospital","ror":"https://ror.org/01gxs7p86","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1281704429","https://openalex.org/I4210105554"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"William S. Weintraub","raw_affiliation_strings":["Christiana Care Health System, Center for Heart & Vascular Health, Newark, Delaware,","Christiana Care Health System, Center for Heart & Vascular Health, Newark, Delaware 19718, USA. wweintraub@christianacare.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christiana Care Health System, Center for Heart & Vascular Health, Newark, Delaware,","institution_ids":["https://openalex.org/I1281704429"]},{"raw_affiliation_string":"Christiana Care Health System, Center for Heart & Vascular Health, Newark, Delaware 19718, USA. wweintraub@christianacare.org","institution_ids":["https://openalex.org/I1281704429","https://openalex.org/I4210105554"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5052993534"],"corresponding_institution_ids":["https://openalex.org/I1281704429","https://openalex.org/I4210105554"],"apc_list":{"value":1325,"currency":"USD","value_usd":1325},"apc_paid":null,"fwci":0.4848,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.74750341,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"13","issue":"2","first_page":"107","last_page":"119"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.6592000126838684,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.6592000126838684,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.33180001378059387,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10193","display_name":"Coronary Interventions and Diagnostics","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacoeconomics","display_name":"pharmacoeconomics","score":0.9459999799728394},{"id":"https://openalex.org/keywords/cost-effectiveness-analysis","display_name":"cost-effectiveness analysis","score":0.8479999899864197},{"id":"https://openalex.org/keywords/cost-utility-analysis","display_name":"cost-utility analysis","score":0.8809999823570251},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.8700000047683716},{"id":"https://openalex.org/keywords/clopidogrel","display_name":"clopidogrel","score":1.0},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.9520000219345093},{"id":"https://openalex.org/keywords/value-for-money","display_name":"value for money","score":0.7419999837875366},{"id":"https://openalex.org/keywords/health-care-resource-allocation","display_name":"healthcare resource allocation","score":0.7739999890327454},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.36399999260902405}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8609905242919922},{"id":"https://openalex.org/C2776738588","wikidata":"https://www.wikidata.org/wiki/Q1567856","display_name":"Pharmacoeconomics","level":2,"score":0.7379639148712158},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.6234933137893677},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.5766609311103821},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5589506030082703},{"id":"https://openalex.org/C127454912","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost\u2013benefit analysis","level":2,"score":0.5086065530776978},{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.5039593577384949},{"id":"https://openalex.org/C2781072439","wikidata":"https://www.wikidata.org/wiki/Q5174738","display_name":"Cost-minimization analysis","level":2,"score":0.4372454285621643},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4362828731536865},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.4220021069049835},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3106643557548523},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.21133148670196533},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.13719570636749268},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11190074682235718},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.10206568241119385},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.08591598272323608},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077144","descriptor_name":"Clopidogrel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D003365","descriptor_name":"Costs and Cost Analysis","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009626","descriptor_name":"Terminology as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013988","descriptor_name":"Ticlopidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013988","descriptor_name":"Ticlopidine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D013988","descriptor_name":"Ticlopidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017850","descriptor_name":"Economics, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1177/1074248407313151","doi":"https://doi.org/10.1177/1074248407313151","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1074248407313151","pdf_url":null,"source":{"id":"https://openalex.org/S130832228","display_name":"Journal of Cardiovascular Pharmacology and Therapeutics","issn_l":"1074-2484","issn":["1074-2484","1940-4034"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:18495905","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18495905","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular pharmacology and therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1007.7466","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1007.7466","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cpt.sagepub.com/content/13/2/107.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W9008068","https://openalex.org/W311320695","https://openalex.org/W1553345686","https://openalex.org/W1593173821","https://openalex.org/W1595046345","https://openalex.org/W1964424379","https://openalex.org/W1967219156","https://openalex.org/W1970028082","https://openalex.org/W1973551591","https://openalex.org/W1976080636","https://openalex.org/W1977897138","https://openalex.org/W1984803994","https://openalex.org/W1985381229","https://openalex.org/W1990163182","https://openalex.org/W1990549635","https://openalex.org/W1994349832","https://openalex.org/W2001688139","https://openalex.org/W2009367393","https://openalex.org/W2011000634","https://openalex.org/W2034283747","https://openalex.org/W2041695326","https://openalex.org/W2047088941","https://openalex.org/W2053033550","https://openalex.org/W2053379248","https://openalex.org/W2060513754","https://openalex.org/W2067034884","https://openalex.org/W2073950136","https://openalex.org/W2081083774","https://openalex.org/W2084673482","https://openalex.org/W2090629794","https://openalex.org/W2097258698","https://openalex.org/W2115131213","https://openalex.org/W2121175754","https://openalex.org/W2128622764","https://openalex.org/W2136229214","https://openalex.org/W2143795636","https://openalex.org/W2144512539","https://openalex.org/W2162886638","https://openalex.org/W2166302161","https://openalex.org/W2280273530","https://openalex.org/W2298418358","https://openalex.org/W2321689713","https://openalex.org/W2336413601","https://openalex.org/W2337305755","https://openalex.org/W2341112456","https://openalex.org/W2491061016","https://openalex.org/W3109503206"],"related_works":["https://openalex.org/W2412796869","https://openalex.org/W2038352116","https://openalex.org/W4381085459","https://openalex.org/W2597917715","https://openalex.org/W2161370825","https://openalex.org/W2078589080","https://openalex.org/W2025543509","https://openalex.org/W7134974411","https://openalex.org/W154671519","https://openalex.org/W4410586220"],"abstract_inverted_index":{"The":[0,92,101],"rising":[1],"cost":[2,32,37,49,60,63,66,79,99],"of":[3,22,29,41,50,67,76,103,116,122,133,141,152],"drug":[4],"therapy":[5],"has":[6],"been":[7],"accompanied":[8],"by":[9],"demands":[10],"from":[11],"payers":[12],"for":[13,20,74,124],"pharmacoeconomic":[14,120,134],"studies":[15],"to":[16,54,57,71,107,148],"assess":[17],"the":[18,48,109,142,145,150],"value":[19],"money":[21],"new":[23],"treatments.":[24],"There":[25],"are":[26,96],"5":[27],"types":[28],"such":[30,85],"analyses:":[31],"analysis":[33],"(evaluates":[34,47,65,81],"only":[35],"costs);":[36],"minimization":[38],"(compares":[39],"costs":[40],"treatments":[42],"with":[43,112],"identical":[44],"outcomes);":[45],"cost-effectiveness":[46,97],"treatment":[51,68],"in":[52,69,89],"relation":[53,70],"clinical":[55,83],"benefit":[56,80,151],"derive":[58],"a":[59,113],"per":[61],"outcome);":[62],"utility":[64],"survival":[72],"adjusted":[73],"quality":[75],"life,)":[77],"and":[78,98],"all":[82],"outcomes,":[84],"as":[86,128],"prolonged":[87],"life,":[88],"monetary":[90],"terms).":[91],"most":[93],"commonly":[94],"used":[95],"utility.":[100],"aim":[102],"this":[104],"article":[105],"is":[106],"provide":[108],"nonexpert":[110],"reader":[111],"basic":[114],"understanding":[115,132],"these":[117],"analyses,":[118],"using":[119],"evaluations":[121],"clopidogrel":[123],"acute":[125],"coronary":[126],"syndromes":[127],"examples.":[129],"Greater":[130],"clinician":[131],"principles":[135],"(and":[136],"pitfalls)":[137],"will":[138],"enhance":[139],"input":[140],"physicians":[143],"into":[144],"decision-making":[146],"process":[147],"maximize":[149],"limited":[153],"health":[154],"care":[155],"resources.":[156]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}